EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C30H30F2N6O3 |
| Net Charge | 0 |
| Average Mass | 560.605 |
| Monoisotopic Mass | 560.23475 |
| SMILES | C=CC(=O)N1CCN(c2nc(=O)n(-c3c(C)ccnc3C(C)C)c3nc(-c4c(O)cccc4F)c(F)cc23)[C@@H](C)C1 |
| InChI | InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1 |
| InChIKey | NXQKSXLFSAEQCZ-SFHVURJKSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| sotorasib (CHEBI:178199) has role antineoplastic agent (CHEBI:35610) |
| sotorasib (CHEBI:178199) is a N-acylpiperazine (CHEBI:46844) |
| sotorasib (CHEBI:178199) is a acrylamides (CHEBI:22216) |
| sotorasib (CHEBI:178199) is a methylpyridines (CHEBI:25340) |
| sotorasib (CHEBI:178199) is a monofluorobenzenes (CHEBI:83575) |
| sotorasib (CHEBI:178199) is a phenols (CHEBI:33853) |
| sotorasib (CHEBI:178199) is a pyridopyrimidine (CHEBI:38932) |
| sotorasib (CHEBI:178199) is a tertiary amino compound (CHEBI:50996) |
| sotorasib (CHEBI:178199) is a tertiary carboxamide (CHEBI:140326) |
| IUPAC Name |
|---|
| 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one |
| INNs | Source |
|---|---|
| sotorasib | WHO MedNet |
| sotorasib | WHO MedNet |
| sotorasib | WHO MedNet |
| sotorasibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| AMG 510 | ChemIDplus |
| AMG-510 | ChemIDplus |
| AMG510 | ChemIDplus |
| Brand Name | Source |
|---|---|
| Lumakras | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:2296729-00-3 | ChemIDplus |
| Citations |
|---|